NEWSCIENTIST  |  skin

Landmark vitiligo cream targets immune cells that disrupt pigmentation

标志性白癜风乳膏靶向破坏色素的免疫细胞

Landmark vitiligo cream targets immune cells that disrupt pigmentation
2026-02-24  594  中等
字体

The cream, which is already available in the US, is sold under the name Opzelura. It treats non-segmental vitiligo, which occurs when symmetrical white patches appear on both sides of the body. This is thought to be caused by the immune system attacking melanocytes, the cells that make the pigment melanin, which gives skin colour.

请登录后继续阅读完整文章

还没有账号?立即注册

成为会员后您将享受无限制的阅读体验,并可使用更多功能,了解更多


免责声明:本文来自网络公开资料,仅供学习交流,其观点和倾向不代表本站立场。